In this study, we utilized high-dimensional single-cell analyses to understand the characteristics of tumor-associated myeloid cells and lymphoid cells in glioblastoma patients treated with or without neoadjuvant anti-PD-1 checkpoint blockade immunotherapy. This evidence concerns the gene PDCD1 and neoplasm.